Document is current
Any future updates will be listed below
-
Authors
Li, Xiangrui
Deng, Li
Xie, Hailun
Li, Shuqun
Zhao, Hong
Liu, Tong
Liu, Xiaoyue
Lin, Shiqi
Liu, ChengAn
Shi, Han-Ping
-
Funding
Funding for this research was provided by:
National Key Research and Development Program (No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600, No. 2022YFC2009600)
- License Information
-
More Information
Article History
Received: 1 April 2024
Accepted: 12 March 2025
First Online: 25 March 2025
Declarations
:
: This study was designed as a prospective cohort study and was conducted in accordance with the Declaration of Helsinki. All participants signed an informed consent form and this study was approved by the Institutional Review Board of each hospital (Guigang People’s Hospital, Bethune First Hospital of Jilin University, Fujian Cancer Hospital, West China Hospital of Sichuan University, Chongqing Third People’s Hospital, Foshan First People’s Hospital, Zhejiang Cancer Hospital, Yunnan Cancer Hospital, The First Affiliated Hospital of Sun Yat-sen University, Anhui Cancer Hospital, Chongqing Cancer Hospital, Chinese Academy of Medical Sciences Cancer Hospital, The First Affiliated Hospital of Kunming Medical University, Chongqing Daping Hospital, Tianjin Medical University Cancer Hospital, Wuhan Tongji Hospital, Xingtai People’s Hospital) (Registration number: ChiCTR180002032).
: Consent for publication was obtained from all co-author.
: The authors declare no competing interests.
